Relationship between Mecp2 and NFκb signaling during neural differentiation of P19 cells

Brain Research

Volumn 1490, Issue , 2013, Pages 35-42

  O'Driscoll, Cliona ^a,b   Kaufmann, Walter E ^a,c   Bressler, Joseph ^a,b  

^a KENNEDY KRIEGER INSTITUTE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Development; Methyl DNA binding protein 2; NF B; P19 embryonic carcinoma cells; Tumor necrosis factor

Indexed keywords

BETA TUBULIN; I KAPPA B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; METHYL CPG BINDING PROTEIN 2; PHORBOL 13 ACETATE 12 MYRISTATE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; EMBRYO INDUCTION; EMBRYONAL CARCINOMA; GENE ACTIVITY; MOUSE; NERVE CELL DIFFERENTIATION; NONHUMAN; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; REPORTER GENE;

BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL LINE, TUMOR; ENZYME ACTIVATORS; GENES, REPORTER; HUMANS; IMMUNOHISTOCHEMISTRY; METHYL-CPG-BINDING PROTEIN 2; NEURONS; NF-KAPPA B; PLURIPOTENT STEM CELLS; PROTEIN KINASE C; REAL-TIME POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84871295386     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2012.10.041     Document Type: Article

References (41)

1. K.M. Aber, P. Nori, S.M. MacDonald, G. Bibat, M.H. Jarrar, and W.E. Kaufmann Methyl-CpG-binding protein 2 is localized in the postsynaptic compartment: an immunochemical study of subcellular fractions Neuroscience 116 2003 77 80
2. R.E. Amir, I.B. Van den Veyver, M. Wan, C.Q. Tran, U. Francke, and H.Y. Zoghbi Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 Nat. Genet. 23 1999 185 188
3. G. Bain, W.J. Ray, M. Yao, and D.I. Gottlieb From embryonal carcinoma cells to neurons: the P19 pathway Bioessays 16 1994 343 348
4. M.C. Boersma, E.C. Dresselhaus, L.M. De Biase, A.B. Mihalas, D.E. Bergles, and M.K. Meffert A requirement for nuclear factor-kappaB in developmental and plasticity-associated synaptogenesis J. Neurosci. 31 2011 5414 5425
5. K. Bomsztyk, J.W. Rooney, T. Iwasaki, N.A. Rachie, S.K. Dower, and C.H. Sibley Evidence that interleukin-1 and phorbol esters activate NF-kappa B by different pathways: role of protein kinase C Cell Regul. 2 1991 329 335
6. P. Carter, J. Downs, A. Bebbington, S. Williams, P. Jacoby, W.E. Kaufmann, and H. Leonard Stereotypical hand movements in 144 subjects with Rett syndrome from the population-based Australian database Mov. Disord. 25 2010 282 288
7. L.W. Daniel, F. Civoli, M.A. Rogers, P.K. Smitherman, P.A. Raju, and M. Roederer ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha Cancer Res. 55 1995 4844 4849
8. B.E. Deverman, and P.H. Patterson Cytokines and CNS development Neuron 64 2009 61 78
9. M.H. Farah, J.M. Olson, H.B. Sucic, R.I. Hume, S.J. Tapscott, and D.L. Turner Generation of neurons by transient expression of neural bHLH proteins in mammalian cells Development 127 2000 693 702
10. M.F. Finley, N. Kulkarni, and J.E. Huettner Synapse formation and establishment of neuronal polarity by P19 embryonic carcinoma cells and embryonic stem cells J. Neurosci. 16 1996 1056 1065
11. K.C. Hite, V.H. Adams, and J.C. Hansen Recent advances in MeCP2 structure and function Biochem. Cell Biol. 87 2009 219 227
12. A. Hoffmann, G. Natoli, and G. Ghosh Transcriptional regulation via the NF-kappaB signaling module Oncogene 25 2006 6706 6716
13. H.S. Huang, G.M. Kubish, T.M. Redmond, D.L. Turner, R.C. Thompson, G.G. Murphy, and M.D. Uhler Direct transcriptional induction of Gadd45gamma by Ascl1 during neuronal differentiation Mol. Cell. Neurosci. 44 2010 282 296
14. K. Hughes, S. Edin, A. Antonsson, and T. Grundstrom Calmodulin-dependent kinase II mediates T cell receptor/CD3- and phorbol ester-induced activation of IkappaB kinase J. Biol. Chem. 276 2001 36008 36013
15. M.H. Jarrar, C.G. Danko, S. Reddy, Y.J. Lee, G. Bibat, and W.E. Kaufmann MeCP2 expression in human cerebral cortex and lymphoid cells: immunochemical characterization of a novel higher-molecular-weight form J. Child Neurol. 18 2003 675 682
16. B. Kaltschmidt, and C. Kaltschmidt NF-kappaB in the nervous system Cold Spring Harb. Perspect. Biol. 1 2009 a001271
17. C.D. Katsetos, M.M. Herman, and S.J. Mork Class III beta-tubulin in human development and cancer Cell Motil. Cytoskeleton 55 2003 77 96
18. W.E. Kaufmann, M.V. Johnston, and M.E. Blue MeCP2 expression and function during brain development: implications for Rett syndrome's pathogenesis and clinical evolution Brain Dev. 27 Suppl. 1 2005 S77 S87
19. T. Kawai, and S. Akira Toll-like receptor downstream signaling Arthritis Res. Ther. 7 2005 12 19
20. Krawetz, R.J.; Taiani, J.; Greene, A.; Kelly, G.M.; Rancourt, D.E.;2011. Inhibition of Rho kinase regulates specification of early differentiation events in P19 embryonal carcinoma stem cells. PLoS One 6, e26484.
21. C.S. Loat, S. Curran, C.M. Lewis, J. Duvall, D. Geschwind, P. Bolton, and I.W. Craig Methyl-CpG-binding protein 2 polymorphisms and vulnerability to autism Genes Brain Behav. 7 2008 754 760
22. P.A. MacPherson, S. Jones, P.A. Pawson, K.C. Marshall, and M.W. McBurney P19 cells differentiate into glutamatergic and glutamate-responsive neurons in vitro Neuroscience 80 1997 487 499
23. M.W. McBurney, K.R. Reuhl, A.I. Ally, S. Nasipuri, J.C. Bell, and J. Craig Differentiation and maturation of embryonal carcinoma-derived neurons in cell culture J. Neurosci. 8 1988 1063 1073
24. G. Miltenberger-Miltenyi, and F. Laccone Mutations and polymorphisms in the human methyl CpG-binding protein MECP2 Hum. Mutat. 22 2003 107 115
25. B.C. Mullaney, M.V. Johnston, and M.E. Blue Developmental expression of methyl-CpG binding protein 2 is dynamically regulated in the rodent brain Neuroscience 123 2004 939 949
26. R.P. Nagarajan, A.R. Hogart, Y. Gwye, M.R. Martin, and J.M. LaSalle Reduced MeCP2 expression is frequent in autism frontal cortex and correlates with aberrant MECP2 promoter methylation Epigenetics 1 2006 e1 11
27. X. Nan, F.J. Campoy, and A. Bird MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin Cell 88 1997 471 481
28. X. Nan, H.H. Ng, C.A. Johnson, C.D. Laherty, B.M. Turner, R.N. Eisenman, and A. Bird Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex Nature 393 1998 386 389
29. X. Nan, J. Hou, A. Maclean, J. Nasir, M.J. Lafuente, X. Shu, S. Kriaucionis, and A. Bird Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation Proc. Natl. Acad. Sci. USA 104 2007 2709 2714
30. A. O'Mahony, J. Raber, M. Montano, E. Foehr, V. Han, S.M. Lu, H. Kwon, A. LeFevour, S. Chakraborty-Sett, and W.C. Greene NF-kappaB/Rel regulates inhibitory and excitatory neuronal function and synaptic plasticity Mol. Cell. Biol. 26 2006 7283 7298
31. C.A. Pardo, D.L. Vargas, and A.W. Zimmerman Immunity, neuroglia and neuroinflammation in autism Int. Rev. Psychiatry 17 2005 485 495
32. P.H. Patterson Modeling autistic features in animals Pediatr. Res. 69 2011 34R 40R
33. A. Romano, R. Freudenthal, E. Merlo, and A. Routtenberg Evolutionarily-conserved role of the NF-kappaB transcription factor in neural plasticity and memory Eur. J. Neurosci. 24 2006 1507 1516
34. V.F. Shih, R. Tsui, A. Caldwell, and A. Hoffmann A single NFkappaB system for both canonical and non-canonical signaling Cell Res. 21 2011 86 102
35. H.M. Shin, M.H. Kim, B.H. Kim, S.H. Jung, Y.S. Kim, H.J. Park, J.T. Hong, K.R. Min, and Y. Kim Inhibitory action of novel aromatic diamine compound on lipopolysaccharide-induced nuclear translocation of NF-kappaB without affecting IkappaB degradation FEBS Lett. 571 2004 50 54
36. M. Tobe, Y. Isobe, H. Tomizawa, T. Nagasaki, H. Takahashi, T. Fukazawa, and H. Hayashi Discovery of quinazolines as a novel structural class of potent inhibitors of NF-kappa B activation Bioorg. Med. Chem. 11 2003 383 391
37. G.G. Turrigiano More than a sidekick: glia and homeostatic synaptic plasticity Trends Mol. Med. 12 2006 458 460
38. M.A. van der Heyden, and L.H. Defize Twenty one years of P19 cells: what an embryonal carcinoma cell line taught us about cardiomyocyte differentiation Cardiovasc. Res. 58 2003 292 302
39. D.L. Vargas, C. Nascimbene, C. Krishnan, A.W. Zimmerman, and C.A. Pardo Neuroglial activation and neuroinflammation in the brain of patients with autism Ann. Neurol. 57 2005 67 81
40. D.H. Yasui, S. Peddada, M.C. Bieda, R.O. Vallero, A. Hogart, R.P. Nagarajan, K.N. Thatcher, P.J. Farnham, and J.M. Lasalle Integrated epigenomic analyses of neuronal MeCP2 reveal a role for long-range interaction with active genes Proc. Natl. Acad. Sci. USA 104 2007 19416 19421
41. J.I. Young, E.P. Hong, J.C. Castle, J. Crespo-Barreto, A.B. Bowman, M.F. Rose, D. Kang, R. Richman, J.M. Johnson, S. Berget, and H.Y. Zoghbi Regulation of RNA splicing by the methylation-dependent transcriptional repressor methyl-CpG binding protein 2 Proc. Natl. Acad. Sci. USA 102 2005 17551 17558